Table 1 Patients and tumour characteristics
(Cases) | hTERT mRNA (copies) | (Cases) | Telomerase activity (TPG) | |
|---|---|---|---|---|
Sex | ||||
Male | 44 | 61.74±130.94 | 27 | 445.8±792.5 |
Female | 19 | 37.48±90.80 | 12 | 403.4±809.6 |
Age | ||||
0–11 months | 12 | 27.28±62.94 | 7 | 458.1±990.0 |
12–23 months | 18 | 57.85±97.72 | 12 | 722.3±1214.3 |
2–3 years | 20 | 21.14±48.34 | 10 | 122.8±269.1 |
4–14 years | 13 | 130.32±210.93 | 10 | 687.5±689.8 |
PRETEXT | ||||
I | 6 | 2.56±4.88 | 5 | 101.5±207.3 |
II | 22 | 56.02±160.07 | 15 | 184.4±514.1 |
III | 20 | 62.84±90.01 | 8 | 624.4±998.1 |
IV | 11 | 65.55±106.82 | 9 | 579.7±1045.6 |
Unknown | 4 | 25.76±50.09 | 2 | 630.1±890.6 |
Stage | ||||
I | 9 | 1.83±4.03 | 6 | 86.4±189.0 |
II | 17 | 17.49±46.34 | 13 | 174.1±545.8 |
IIIA | 13 | 39.63±61.47 | 5 | 333.1±706.7 |
IIIB | 10 | 105.50±134.93 | 8 | 915.0±1072.0 |
IV | 14 | 104.41±197.70 | 7 | 729.9±969.6 |
Histology | ||||
Well | 33 | 58.63±138.63 | 20 | 574.5±878.2 |
Poorly | 27 | 51.21±96.00 | 17 | 312.8±704.3 |
Others | 3 | 3.57±3.37 | 2 | 34.1±8.37 |
Preoperative chemotherapy | ||||
Yes | 34 | 63.61±149.14 | 19 | 486.6±802.7 |
No | 29 | 40.18±65.60 | 20 | 381.6±789.7 |
Curative surgery | ||||
Yes | 39 | 56.91±130.29 | 30 | 397.4±758.8 |
No | 24 | 46.19±96.98 | 9 | 550.3±914.6 |
Prognosis | ||||
Survived with evidence-free | 50 | 33.25±72.11 | 30 | 252.7±604.2 |
Recurrence/died of disease | 13 | 128.11±207.25 | 9 | 1032.8±1046.0 |
